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Background: Demineralised bone matrix (DBM) has shown to be effective in enhancing posterior fusion of the
spine. Several animal studies and clinical investigations in humans showed its successful remodelling. The use of
allogenic matrix may decrease the need of autologous bone graft and therefore helps prevent corresponding
donor site morbidity. Since DBM products are very expensive, the question arises, whether it is completely
remodelled into new bone, and therefore truly is comparable to autologous cancellous bone graft. To our
knowledge there is no report of a consecutive series of patients where ex vivo histological analysis after
postero-lateral fusion of the spine was performed.
Methods: Osseous biopsies of nine consecutive patients who underwent postero-lateral fusion of the spine for
trauma were obtained at the time of elective removal of the hardware. Histological samples were then analyzed
on ground and thin sections stained with toluidine blue and von Kossa stainings.
Results: Time span between index operation and removal of the metal ranged between 6 and 18 month.
Histological analysis showed good incorporation and overall remodelling of DBM into new bone in all patients.
No foreign body reaction was visible and new bone formation progressed time dependently with DBM in situ.
Four out of nine patients showed more than 50% new bone formation after one year.
Conclusion: DBM shows good overall remodelling properties in histological analysis and therefore seems to be
an effective adjunct in postero-lateral fusion of the spine. Furthermore, DBM substitution increases over time.
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The current gold standard in thoraco-lumbar fusion
surgery of the spine is posterolateral arthrodesis using
autologous bone graft from the iliac crest in addition to
instrumentation [1,2]. Although autologous bone grafts
provide ideal biological properties, graft harvesting may
cause severe donor site morbidity [3-8]. Therefore, spine
surgeons increasingly tend to use allogenic bone graft as
osteoconductive and osteoinductive carriers enhancing
solid fusion without disadvantages of graft harvesting.
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reproduction in any medium, provided the orreliable alternative in terms of its fusion capacities in
several animal models as well as in clinical investigations
in humans [9-17]. While histological performance of
DBM was extensively investigated in animal fusion models
[9-14], only few ex vivo studies were reported proving
efficacy of this generally very expensive material. These
studies dealt either with dental surgery procedures or idio-
pathic scoliosis in a child, whereas no ex vivo investigation
was reported focusing on adult spine surgery [18,19]. To
our knowledge, the present study is the first report of
histological performance of DBM in a consecutive series
of patients who underwent posterolateral fusion of the
spine. The goal of our investigation therefore was to clarify
whether DBM incorporates to the surrounding bone oral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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DBM is related to its time in situ (“dwell time”).Methods
Patients
In a retrospective study design a series of patients who
underwent dorsal instrumentation and postero-lateral
fusion of the thoraco-lumbar spine using DBM as bone
substitute and subsequently were scheduled for elective
removal of dorsal instrumentation hardware were inclu-
ded in our study. Patients with diagnosed systemic
infection and septic loosening were excluded. Patients
routinely were asked before surgery if a sample of the
bony debris removed during uncovering of the implants
may be used for histological analysis instead of been
thrown away. Formal ethical approval of waste by-
product analysis was not necessary. Still, all patients gave
their written informed consent. At the time of hardware
removal, small osseous biopsies then were obtained as
by-product while uncovering the metallic rods.Histology
All bone samples were processed equally with primary
fixation in 12% formalin solution. After ascending alco-
hol series and degreasing by xylene under vacuum con-
ditions, the non-decalcified specimens were infiltrated
and embedded in polymethylmetacrylate as described
previously [20,21]. Ground (ca. 40 μm) and thin (5 μm)
sections were prepared and (surface-) stained with either
toluidin blue (TB) or von Kossa/McNeal (only thin sec-
tions). Histological sections were evaluated qualitatively
and semiquantitatively. The latter was performed in the
van-Kossa/McNeill sections, where DBM could well be
distinguished from the newly formed bone and adjacent
soft tissue. Semi-quantitative scores were given indicat-
ing the percentage of remaining DBM, resp. new bone
formation (Table 1).Table 1 Semi-quantitative histological evaluation
Patient Age Fusion levels DBX® in situ (month) DBX® resi
1 31 T10-T12 7 +
2 52 T11-L1 18 -
3 50 T11-L1 8 +
4 39 T12-L2 9 ++
5 39 T12-L2 8 ++
6 64 T5-T9 8 +++
7 30 T12-L2 17 -
8 46 T2-T5 6 ++
9 48 T11-L1 9 ++
Table 1: Case related histological analysis with scores: (+) = <25%, (++) = <26-50%, (
and newly formed bone.Results
Nine patients (6 male and 3 female, 30 to 64 years old)
that were scheduled for elective removal of dorsal in-
strumentation hardware over a 12-month time period
were included in our study. Indications for hardware
removal was subjectively disturbing hardware and the
explicit patients wish to remove the implants in 8 out of
nine patients. In one patient aseptic implant loosening
was diagnosed. Osseous fusion was confirmed radio-
logically in all cases. For index operation 10 cc of DBX
Mix® (SYNTHES, Oberdorf, Switzerland), a demine-
ralised bone matrix substitute embedded in sodium
hyaluronate mixed with cortical allograft bone chips,
was used. The fusion bed was prepared using a high
speed drill before DBX Mix® was added. No additional
autologous bone graft harvesting of the iliac crest was
conducted in all cases. Except of one female patient who
presented pathological osteoporotic fracture with con-
secutive stenosis of the spinal canal, all other patients
were initially operated for unstable traumatic vertebral
fractures and healthy otherwise.
The time period between index operation and hardware
removal and osseous biopsies respectively, was between 6
and 18 month (mean 10 month). No intraoperative and
no postoperative complication including infection or
extensive hematoma formation occurred in any patient.
At the time of hardware removal, intraoperative testing
showed solid fusion of all bridged segments in all cases
and DBX Mix® seemed to be remodelled and integrated
within the fusion mass.
Qualitative and semi-quantitative, histological analysis
showed time dependent partial remodelling in some sam-
ples and almost complete remodelling of the DBM into
new bone in other cases. Detailed assessment showed not
only reorganization of demineralised matrix but also of
the autologous and allogenic bone chips generated
through preparing the graft bed during initial surgery.
While samples of patients with shorter “dwell time” ofduals (+/++/+++/++++) New bone formation (+/++/+++/+++++)
+++
++++
+++
++
++
+
++++
++
++
+++) = <51-75% and (++++) < 76-100% indicating relationship between DBM
Figure 1 Complete transformation of DBX® into new bone in a patient with in situ for 18 month. Dark blue bone represents new woven
bone matrix (*), lighter blue is already remodeled lamellar bone (arrow) (ground sections, PMMA, staining toluidine blue surface staining).
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DBM and chips residuals, samples with longer stays
showed almost complete substitution of DBM with a lot
of new bone mineralization and progressive remodelling
of cortical chips (see Figures 1 and 2 and Table 1). Figure 3
shows the “creeping substitution” [22] in a case of 6 month
DBM in situ. Precipitation of new osteoid and extensive
matrix calcification is shown in Figure 4. On the thin
slices different phases of the reorganizational process
could prove osteoinductive and osteoconductive capacities
of the DBM. For case related analysis see also Table 1.Figure 2 Partial transformation of DBX® into new bone in a patient wDiscussion
Since DBM for clinical use is very expensive compared
to autologous bone grafting, effectiveness of such prod-
ucts is mandatory. While DBM gel as an autograft
extender showed improved fusion in dogs [7], heterol-
ogous DBM provided equal fusion capacity as auto-
logous bone graft in rats [8]. Comparable results were
also obtained when DBM was used as partial substitute
of autologous bone graft in a postero-lateral fusion model
in rabbits [9]. In another rabbit model, DBM showed
osteoinductive ability, while allogenic deep-frozen corticalith in situ for 8 month. The DBX® residuals (light blue) are still visible.
Figure 3 «Creeping substitution»: demineralized bone matrix is slowly resorbed and simultaneously replaced by new bone. Blacks
indicates already mineralized bone matrix, turquoise pictures osteoid seams (arrows) (5 μm sections, PMMA, Staining von Kossa/McNeall).
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showed equal fusion rates of postero-lateral arthrodesis
performed in patients with local autologous bone graft
augmented with DBM and in those with autologous bone
graft from the iliac crest alone [13]. Radiographic progres-
sion of the fusion with time was also shown when DBM
was used as bone graft extender to decrease the need of
autologous bone graft [14]. Intra-individual comparison of
DBM augmented autograft at one side and autograft
without adjunct at the contralateral side in patients whoFigure 4 Extensive matrix calcification (black) during the substitution
remaining matrix and newly formed bone (5 μm section, PMMA, Staining vunderwent postero-lateral fusion showed equal results in
radiographic assessment [15]. An ex vivo histological ana-
lysis of different types of DBM products used for sinus lift
procedures in oral surgery showed superiority of DBX® in
terms of new bone formation and low residual demine-
ralised matrix compared to other products [16]. In a
recently published case report of a 7-year old male child
suffering from idiopathic scoliosis who underwent poster-
ior spinal fusion, DBM was used as sole graft source.
Eleven month later on the basis of a routine surgicalprocess. Note precipitation of calcium at the border between
on Kossa/McNeall).
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site and histological analysis was performed. In this case,
investigators found only mature bone with no residual
DBM graft and concluded therefore DBM to be fully in-
corporated in the fusion mass [17].
Our results tend to support these overall findings of
reliable remodelling of DBM to new bone. The histo-
logical analysis showed significant new bone formation
and decreasing residual DBM material in all of our
patients depending on the time span DBM was in situ.
Additionally, cortical bone chips converted as well in the
same manner. The verifiable process of “creeping subs-
titution” allowed confirming active incorporation and
reorganisation of the demineralised matrix.
Further analysis should be made to determine whether
additional cortical bone chips are necessary to enhance
new bone formation or if DBM putty alone provides best
performance in postero-lateral fusion of the spine. Com-
parative study designs will help to analyse the bone
remodelling patterns of different treatment courses such
as the use of DBM versus autologous bone grafting or
spontaneous fusion based on posttraumatic hematoma.
Limitations of our study are the small number of
patients included in the collective and the lack of quanti-
tative morphometric analysis based on standardized
bone samples, which of course was not applicable in the
clinical setting. Furthermore the results of our investi-
gation are not applicable to postero-lateral fusion in
general since our study population is relatively youg
(mean age 44 years) and the reason for a fusion was
trauma in eight of nine cases. Additionally there may be
a bias with regard to the harvesting site of the bony
samples, which were all taken around the rods during
implant removal and therefore may not be representative
for all fusion areas.
Conclusion
DBX Mix® shows reliable remodelling in histological
analysis and therefore seems to be an effective in
postero-lateral fusion of the spine in the presented study
population. Furthermore, DBM substitution increases
over time.
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